Craig A. Collard

Craig A. Collard (board member) discloses dealings in 4 companies, chiefly Heron Therapeutics, Inc. /DE/, TerrAscend Corp. and Opiant Pharmaceuticals, Inc. In total, 41 filings cover trades dated from 15 June 2021 to 31 July 2026.

Every open-market trade on record is a purchase: 9 purchases worth €834k, and no sale. The totals exclude 2 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 11 share grants and 19 option exercises.

A typical purchase (the median) is worth €114k. 6 out of 9 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

Most recently, on 3 August 2026, the filings show an option exercise in Heron Therapeutics, Inc. /DE/. The last insider purchase was made public on 17 November 2023, 1,066 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.